
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipelin... Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.27 | -13.1067961165 | 2.06 | 2.06 | 1.745 | 287132 | 1.82503565 | CS |
4 | -0.97 | -35.1449275362 | 2.76 | 2.89 | 1.745 | 1273123 | 2.39334771 | CS |
12 | -0.76 | -29.8039215686 | 2.55 | 9.79 | 1.53 | 7116015 | 5.50672654 | CS |
26 | -0.83 | -31.679389313 | 2.62 | 9.79 | 1.53 | 3141746 | 5.47918132 | CS |
52 | -4.15 | -69.8653198653 | 5.94 | 10.35 | 1.53 | 1704683 | 5.61693103 | CS |
156 | -94.546 | -98.1419199469 | 96.336 | 261.36 | 1.53 | 1086688 | 65.32890631 | CS |
260 | -322.21 | -99.4475308642 | 324 | 699.84 | 1.53 | 943198 | 130.50112655 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.